Zydus Lifesciences Ltd - 532321 - Announcement Under Regulation 30
Demand order from GST department06-12-2023
06-12-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives Final Approval from the USFDA for Methylene Blue Injection06-12-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Ivabradine Tablets, 5 mg and 7.5 mg01-12-2023
Zydus Lifesciences Ltd - 532321 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of loss of share certificate / duplicate share certificate30-11-2023
Cadila Pharmaceuticals inaugurates Rs 200-crore API plant in Dahej, aims to expand to new markets
The plant adheres to the company's environmental initiatives, firm says27-11-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Call Q2 FY2411-11-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
The Newspaper Publication of Notice of loss of share certificate of the Company, published in the Financial Express English and Gujarati Editions, both on November 11, 2023.11-11-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus and Torrent sign licensing agreement for co-marketing Saroglitazar Mg, a critical treatment for chronic liver diseases in India.10-11-2023
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
The copy of newspaper cutting with regard to publication of extract of unaudited financial results for the quarter / half year ended on September 30, 2023 in Financial Express on November 8, 2023.08-11-2023